Cargando…

Cardiometabolic Risk Profiles in Patients With Impaired Fasting Glucose and/or Hemoglobin A1c 5.7% to 6.4%: Evidence for a Gradient According to Diagnostic Criteria: The PREDAPS Study

It has been suggested that the early detection of individuals with prediabetes can help prevent cardiovascular diseases. The purpose of the current study was to examine the cardiometabolic risk profile in patients with prediabetes according to fasting plasma glucose (FPG) and/or hemoglobin A1c (HbA1...

Descripción completa

Detalles Bibliográficos
Autores principales: Giráldez-García, Carolina, Sangrós, F. Javier, Díaz-Redondo, Alicia, Franch-Nadal, Josep, Serrano, Rosario, Díez, Javier, Buil-Cosiales, Pilar, García-Soidán, F. Javier, Artola, Sara, Ezkurra, Patxi, Carrillo, Lourdes, Millaruelo, J. Manuel, Seguí, Mateu, Martínez-Candela, Juan, Muñoz, Pedro, Goday, Albert, Regidor, Enrique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915900/
https://www.ncbi.nlm.nih.gov/pubmed/26554799
http://dx.doi.org/10.1097/MD.0000000000001935
_version_ 1782438753641431040
author Giráldez-García, Carolina
Sangrós, F. Javier
Díaz-Redondo, Alicia
Franch-Nadal, Josep
Serrano, Rosario
Díez, Javier
Buil-Cosiales, Pilar
García-Soidán, F. Javier
Artola, Sara
Ezkurra, Patxi
Carrillo, Lourdes
Millaruelo, J. Manuel
Seguí, Mateu
Martínez-Candela, Juan
Muñoz, Pedro
Goday, Albert
Regidor, Enrique
author_facet Giráldez-García, Carolina
Sangrós, F. Javier
Díaz-Redondo, Alicia
Franch-Nadal, Josep
Serrano, Rosario
Díez, Javier
Buil-Cosiales, Pilar
García-Soidán, F. Javier
Artola, Sara
Ezkurra, Patxi
Carrillo, Lourdes
Millaruelo, J. Manuel
Seguí, Mateu
Martínez-Candela, Juan
Muñoz, Pedro
Goday, Albert
Regidor, Enrique
author_sort Giráldez-García, Carolina
collection PubMed
description It has been suggested that the early detection of individuals with prediabetes can help prevent cardiovascular diseases. The purpose of the current study was to examine the cardiometabolic risk profile in patients with prediabetes according to fasting plasma glucose (FPG) and/or hemoglobin A1c (HbA1c) criteria. Cross-sectional analysis from the 2022 patients in the Cohort study in Primary Health Care on the Evolution of Patients with Prediabetes (PREDAPS Study) was developed. Four glycemic status groups were defined based on American Diabetes Association criteria. Information about cardiovascular risk factors–body mass index, waist circumference, blood pressure, cholesterol, triglycerides, uric acid, gamma-glutamyltransferase, glomerular filtration–and metabolic syndrome components were analyzed. Mean values of clinical and biochemical characteristics and frequencies of metabolic syndrome were estimated adjusting by age, sex, educational level, and family history of diabetes. A linear trend (P < 0.001) was observed in most of the cardiovascular risk factors and in all components of metabolic syndrome. Normoglycemic individuals had the best values, individuals with both criteria of prediabetes had the worst, and individuals with only one–HbA1c or FPG–criterion had an intermediate position. Metabolic syndrome was present in 15.0% (95% confidence interval: 12.6–17.4), 59.5% (54.0–64.9), 62.0% (56.0–68.0), and 76.2% (72.8–79.6) of individuals classified in normoglycemia, isolated HbA1c, isolated FPG, and both criteria groups, respectively. In conclusion, individuals with prediabetes, especially those with both criteria, have worse cardiometabolic risk profile than normoglycemic individuals. These results suggest the need to use both criteria in the clinical practice to identify those individuals with the highest cardiovascular risk, in order to offer them special attention with intensive lifestyle intervention programs.
format Online
Article
Text
id pubmed-4915900
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-49159002016-07-05 Cardiometabolic Risk Profiles in Patients With Impaired Fasting Glucose and/or Hemoglobin A1c 5.7% to 6.4%: Evidence for a Gradient According to Diagnostic Criteria: The PREDAPS Study Giráldez-García, Carolina Sangrós, F. Javier Díaz-Redondo, Alicia Franch-Nadal, Josep Serrano, Rosario Díez, Javier Buil-Cosiales, Pilar García-Soidán, F. Javier Artola, Sara Ezkurra, Patxi Carrillo, Lourdes Millaruelo, J. Manuel Seguí, Mateu Martínez-Candela, Juan Muñoz, Pedro Goday, Albert Regidor, Enrique Medicine (Baltimore) 6400 It has been suggested that the early detection of individuals with prediabetes can help prevent cardiovascular diseases. The purpose of the current study was to examine the cardiometabolic risk profile in patients with prediabetes according to fasting plasma glucose (FPG) and/or hemoglobin A1c (HbA1c) criteria. Cross-sectional analysis from the 2022 patients in the Cohort study in Primary Health Care on the Evolution of Patients with Prediabetes (PREDAPS Study) was developed. Four glycemic status groups were defined based on American Diabetes Association criteria. Information about cardiovascular risk factors–body mass index, waist circumference, blood pressure, cholesterol, triglycerides, uric acid, gamma-glutamyltransferase, glomerular filtration–and metabolic syndrome components were analyzed. Mean values of clinical and biochemical characteristics and frequencies of metabolic syndrome were estimated adjusting by age, sex, educational level, and family history of diabetes. A linear trend (P < 0.001) was observed in most of the cardiovascular risk factors and in all components of metabolic syndrome. Normoglycemic individuals had the best values, individuals with both criteria of prediabetes had the worst, and individuals with only one–HbA1c or FPG–criterion had an intermediate position. Metabolic syndrome was present in 15.0% (95% confidence interval: 12.6–17.4), 59.5% (54.0–64.9), 62.0% (56.0–68.0), and 76.2% (72.8–79.6) of individuals classified in normoglycemia, isolated HbA1c, isolated FPG, and both criteria groups, respectively. In conclusion, individuals with prediabetes, especially those with both criteria, have worse cardiometabolic risk profile than normoglycemic individuals. These results suggest the need to use both criteria in the clinical practice to identify those individuals with the highest cardiovascular risk, in order to offer them special attention with intensive lifestyle intervention programs. Wolters Kluwer Health 2015-11-06 /pmc/articles/PMC4915900/ /pubmed/26554799 http://dx.doi.org/10.1097/MD.0000000000001935 Text en Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 6400
Giráldez-García, Carolina
Sangrós, F. Javier
Díaz-Redondo, Alicia
Franch-Nadal, Josep
Serrano, Rosario
Díez, Javier
Buil-Cosiales, Pilar
García-Soidán, F. Javier
Artola, Sara
Ezkurra, Patxi
Carrillo, Lourdes
Millaruelo, J. Manuel
Seguí, Mateu
Martínez-Candela, Juan
Muñoz, Pedro
Goday, Albert
Regidor, Enrique
Cardiometabolic Risk Profiles in Patients With Impaired Fasting Glucose and/or Hemoglobin A1c 5.7% to 6.4%: Evidence for a Gradient According to Diagnostic Criteria: The PREDAPS Study
title Cardiometabolic Risk Profiles in Patients With Impaired Fasting Glucose and/or Hemoglobin A1c 5.7% to 6.4%: Evidence for a Gradient According to Diagnostic Criteria: The PREDAPS Study
title_full Cardiometabolic Risk Profiles in Patients With Impaired Fasting Glucose and/or Hemoglobin A1c 5.7% to 6.4%: Evidence for a Gradient According to Diagnostic Criteria: The PREDAPS Study
title_fullStr Cardiometabolic Risk Profiles in Patients With Impaired Fasting Glucose and/or Hemoglobin A1c 5.7% to 6.4%: Evidence for a Gradient According to Diagnostic Criteria: The PREDAPS Study
title_full_unstemmed Cardiometabolic Risk Profiles in Patients With Impaired Fasting Glucose and/or Hemoglobin A1c 5.7% to 6.4%: Evidence for a Gradient According to Diagnostic Criteria: The PREDAPS Study
title_short Cardiometabolic Risk Profiles in Patients With Impaired Fasting Glucose and/or Hemoglobin A1c 5.7% to 6.4%: Evidence for a Gradient According to Diagnostic Criteria: The PREDAPS Study
title_sort cardiometabolic risk profiles in patients with impaired fasting glucose and/or hemoglobin a1c 5.7% to 6.4%: evidence for a gradient according to diagnostic criteria: the predaps study
topic 6400
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915900/
https://www.ncbi.nlm.nih.gov/pubmed/26554799
http://dx.doi.org/10.1097/MD.0000000000001935
work_keys_str_mv AT giraldezgarciacarolina cardiometabolicriskprofilesinpatientswithimpairedfastingglucoseandorhemoglobina1c57to64evidenceforagradientaccordingtodiagnosticcriteriathepredapsstudy
AT sangrosfjavier cardiometabolicriskprofilesinpatientswithimpairedfastingglucoseandorhemoglobina1c57to64evidenceforagradientaccordingtodiagnosticcriteriathepredapsstudy
AT diazredondoalicia cardiometabolicriskprofilesinpatientswithimpairedfastingglucoseandorhemoglobina1c57to64evidenceforagradientaccordingtodiagnosticcriteriathepredapsstudy
AT franchnadaljosep cardiometabolicriskprofilesinpatientswithimpairedfastingglucoseandorhemoglobina1c57to64evidenceforagradientaccordingtodiagnosticcriteriathepredapsstudy
AT serranorosario cardiometabolicriskprofilesinpatientswithimpairedfastingglucoseandorhemoglobina1c57to64evidenceforagradientaccordingtodiagnosticcriteriathepredapsstudy
AT diezjavier cardiometabolicriskprofilesinpatientswithimpairedfastingglucoseandorhemoglobina1c57to64evidenceforagradientaccordingtodiagnosticcriteriathepredapsstudy
AT builcosialespilar cardiometabolicriskprofilesinpatientswithimpairedfastingglucoseandorhemoglobina1c57to64evidenceforagradientaccordingtodiagnosticcriteriathepredapsstudy
AT garciasoidanfjavier cardiometabolicriskprofilesinpatientswithimpairedfastingglucoseandorhemoglobina1c57to64evidenceforagradientaccordingtodiagnosticcriteriathepredapsstudy
AT artolasara cardiometabolicriskprofilesinpatientswithimpairedfastingglucoseandorhemoglobina1c57to64evidenceforagradientaccordingtodiagnosticcriteriathepredapsstudy
AT ezkurrapatxi cardiometabolicriskprofilesinpatientswithimpairedfastingglucoseandorhemoglobina1c57to64evidenceforagradientaccordingtodiagnosticcriteriathepredapsstudy
AT carrillolourdes cardiometabolicriskprofilesinpatientswithimpairedfastingglucoseandorhemoglobina1c57to64evidenceforagradientaccordingtodiagnosticcriteriathepredapsstudy
AT millaruelojmanuel cardiometabolicriskprofilesinpatientswithimpairedfastingglucoseandorhemoglobina1c57to64evidenceforagradientaccordingtodiagnosticcriteriathepredapsstudy
AT seguimateu cardiometabolicriskprofilesinpatientswithimpairedfastingglucoseandorhemoglobina1c57to64evidenceforagradientaccordingtodiagnosticcriteriathepredapsstudy
AT martinezcandelajuan cardiometabolicriskprofilesinpatientswithimpairedfastingglucoseandorhemoglobina1c57to64evidenceforagradientaccordingtodiagnosticcriteriathepredapsstudy
AT munozpedro cardiometabolicriskprofilesinpatientswithimpairedfastingglucoseandorhemoglobina1c57to64evidenceforagradientaccordingtodiagnosticcriteriathepredapsstudy
AT godayalbert cardiometabolicriskprofilesinpatientswithimpairedfastingglucoseandorhemoglobina1c57to64evidenceforagradientaccordingtodiagnosticcriteriathepredapsstudy
AT regidorenrique cardiometabolicriskprofilesinpatientswithimpairedfastingglucoseandorhemoglobina1c57to64evidenceforagradientaccordingtodiagnosticcriteriathepredapsstudy